These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 27506270

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Influence of ethanol on physical state of freeze-dried mannitol.
    Takada A, Nail SL, Yonese M.
    Pharm Res; 2009 May; 26(5):1112-20. PubMed ID: 19184373
    [Abstract] [Full Text] [Related]

  • 23. The physical state of mannitol after freeze-drying: effects of mannitol concentration, freezing rate, and a noncrystallizing cosolute.
    Kim AI, Akers MJ, Nail SL.
    J Pharm Sci; 1998 Aug; 87(8):931-5. PubMed ID: 9687336
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Component crystallization and physical collapse during freeze-drying of L-arginine-citric acid mixtures.
    Yamaki T, Ohdate R, Nakadai E, Yoshihashi Y, Yonemochi E, Terada K, Moriyama H, Izutsu K, Yomota C, Okuda H, Kawanishi T.
    Chem Pharm Bull (Tokyo); 2012 Aug; 60(9):1176-81. PubMed ID: 22976327
    [Abstract] [Full Text] [Related]

  • 28. Effects of Excipient Interactions on the State of the Freeze-Concentrate and Protein Stability.
    Jena S, Horn J, Suryanarayanan R, Friess W, Aksan A.
    Pharm Res; 2017 Feb; 34(2):462-478. PubMed ID: 27981449
    [Abstract] [Full Text] [Related]

  • 29. Use of subambient differential scanning calorimetry to monitor the frozen-state behavior of blends of excipients for freeze-drying.
    Martini A, Kume S, Crivellente M, Artico R.
    PDA J Pharm Sci Technol; 1997 Feb; 51(2):62-7. PubMed ID: 9146035
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Moisture sorption behavior of selected bulking agents used in lyophilized products.
    Fakes MG, Dali MV, Haby TA, Morris KR, Varia SA, Serajuddin AT.
    PDA J Pharm Sci Technol; 2000 Feb; 54(2):144-9. PubMed ID: 10822985
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Mannitol as an Excipient for Lyophilized Injectable Formulations.
    Thakral S, Sonje J, Munjal B, Bhatnagar B, Suryanarayanan R.
    J Pharm Sci; 2023 Jan; 112(1):19-35. PubMed ID: 36030846
    [Abstract] [Full Text] [Related]

  • 34. The impact of protein concentration on mannitol and sodium chloride crystallinity and polymorphism upon lyophilization.
    Dixon D, Tchessalov S, Barry A, Warne N.
    J Pharm Sci; 2009 Sep; 98(9):3419-29. PubMed ID: 18781637
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. In-situ investigation of solid phase evolution during lyophilization of mannitol-based antibody formulations using an XRPD climate chamber.
    Seiler VK, Weber S, Börner M, Witting M, Ehlers S, Nagel N.
    Eur J Pharm Sci; 2023 May 01; 184():106407. PubMed ID: 36809814
    [Abstract] [Full Text] [Related]

  • 38. Influence of the active pharmaceutical ingredient concentration on the physical state of mannitol--implications in freeze-drying.
    Liao X, Krishnamurthy R, Suryanarayanan R.
    Pharm Res; 2005 Nov 01; 22(11):1978-85. PubMed ID: 16132343
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.